Literature DB >> 27398445

Molecular Imaging of CD44-Overexpressing Gastric Cancer in Mice Using T2 MR Imaging.

Hwunjae Lee, Seung-Hyun Yang, Dan Heo, Heyoung Son, Seungjoo Haam, Jin-Suck Suh, Jaemoon Yang, Yong-Min Huh.   

Abstract

Novel diagnostic techniques have been developed in many research area using targetable contrast agents with magnetic resonance imaging (MRI) for cancer diagnosis. For cancer diagnosis, the use of MRI with biocompatible targeting moieties and manganese ferrite nanoparticles (MFNPs) is preferred. Thus, we synthesized MFNPs using a thermal decomposition method which enables sensitive T2 or T2 Turbo Spin Echo (TSE) MRI and coated them with hyaluronic acid (HA). The high targeting ability of HA-MFNPs was observed at MKN-45 cells (gastric cancer cell line) which high-expressing CD44 in contrast with MKN-28 cells which low-expressing CD44. We also prepared the gastric cancer mice model using MKN-45 cells which has the stem-like property was implanted into BALB/c nude mice. And then HA-MFNPs of the T2 contrast enhancement effects and targeting ability were investigated by in vivo MR imaging. As a result of these studies, we conclude that HA coated MFNPs can be effectively used as a novel probes for visualizing gastric cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27398445     DOI: 10.1166/jnn.2016.11782

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  4 in total

Review 1.  Cancer stem cells and nanotechnological approaches for eradication.

Authors:  Gholam Basati; Mojtaba Khaksarian; Saber Abbaszadeh; Hamed Esmaeil Lashgarian; Abdolrazagh Marzban
Journal:  Stem Cell Investig       Date:  2019-11-28

2.  Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3-/- mice transplanted with human PBMCs.

Authors:  Hiromi Ogata-Aoki; Nobuyo Higashi-Kuwata; Shin-Ichiro Hattori; Hironori Hayashi; Matthew Danish; Manabu Aoki; Chiemi Shiotsu; Yumi Hashiguchi; Akinobu Hamada; Hisataka Kobayashi; Hironobu Ihn; Seiji Okada; Hiroaki Mitsuya
Journal:  Antiviral Res       Date:  2017-09-08       Impact factor: 5.970

3.  Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.

Authors:  Zhuanglei Gao; Zhaoxia Li; Jieke Yan; Peilin Wang
Journal:  Drug Des Devel Ther       Date:  2017-09-05       Impact factor: 4.162

4.  Hyaluronic Acid-Stabilized Fe3O4 Nanoparticles for Promoting In Vivo Magnetic Resonance Imaging of Tumors.

Authors:  Weijie Zhang; Zhongyue Zhang; Shitong Lou; Zhiwei Chang; Baohong Wen; Tao Zhang
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.